Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of adjuvant XELOX in Japanese patients Taishi Hata, Hidetoshi Eguchi, M. Umemura et al.|Research Square|2024Cited by 0
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancerTaishi Hata, Hidetoshi Eguchi, Mamoru Uemura et al.|Scientific Reports|2024Cited by 0
Prevalence of <scp>MSI</scp> ‐H/ <scp>dMMR</scp> Colorectal Cancer in Japan: Data From the Clinical Study Group of the University of Osaka‐Colorectal RegistryYoshihiro Morimoto, Hidetoshi Eguchi, Shinichi Yoshioka et al.|Annals of Gastroenterological Surgery|2026Cited by 0